First-in-human Phase I study of EZN-4176, a locked nucleic acid antisense oligonucleotide to exon 4 of the androgen receptor mRNA in patients with castration-resistant prostate cancer. (Q37323018)
Jump to navigation
Jump to search
scientific article published on 29 October 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | First-in-human Phase I study of EZN-4176, a locked nucleic acid antisense oligonucleotide to exon 4 of the androgen receptor mRNA in patients with castration-resistant prostate cancer. |
scientific article published on 29 October 2013 |
Statements
First-in-human Phase I study of EZN-4176, a locked nucleic acid antisense oligonucleotide to exon 4 of the androgen receptor mRNA in patients with castration-resistant prostate cancer (English)
D Bianchini
A Omlin
C Pezaro
R Ferraldeschi
D Mukherji
I Figueiredo
R Riisnaes
A Zivi
A Buchbinder
H I Scher
J de Bono
29 October 2013
1 reference
1 reference